Hans Christian Andersen and the Value of New Cancer Treatments

Saved in:
Bibliographic Details
Published inJNCI : Journal of the National Cancer Institute Vol. 110; no. 5; pp. 441 - 442
Main Authors Schilsky, Richard L, Schnipper, Lowell E
Format Journal Article
LanguageEnglish
Published United States 01.05.2018
Online AccessGet full text

Cover

Author Schilsky, Richard L
Schnipper, Lowell E
Author_xml – sequence: 1
  givenname: Richard L
  surname: Schilsky
  fullname: Schilsky, Richard L
  organization: American Society of Clinical Oncology, Alexandria, VA
– sequence: 2
  givenname: Lowell E
  surname: Schnipper
  fullname: Schnipper, Lowell E
  organization: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29244175$$D View this record in MEDLINE/PubMed
BookMark eNo9kE1Lw0AQhhep2A89eZc9ChK7X9kkF6EEtULRS_W6bDezNCXZ1N0E9d-7pdX3MHN55mV4pmjkOgcIXVNyT0nB5ztn6nm1-2aSnqEJFZIkjJJ0hCaEsCzJ80yM0TSEHYkpmLhAYxaXoFk6QQ9L7QIut74Ofa0dXrgKfACHtatwvwX8oZsBcGfxK3zhUjsDHq896L4F14dLdG51E-DqtGfo_elxXS6T1dvzS7lYJYYz2SdW5htb2TwlrJAiFzRPBQOZgSkopJxongMn0oCtuK0KI0WWGgHxBuKX2vAZuj327n33OUDoVVsHA02jHXRDULTIYuJgEb07osZ3IXiwau_rVvsfRYk6CFMHYeooLNI3p-Jh00L1z_4Z4r_Qt2ib
CitedBy_id crossref_primary_10_1001_jamanetworkopen_2023_24977
crossref_primary_10_15171_ijhpm_2018_66
crossref_primary_10_1038_nrclinonc_2018_27
crossref_primary_10_1016_j_ejca_2021_03_013
crossref_primary_10_1038_s41573_022_00552_x
crossref_primary_10_18632_oncotarget_27112
Cites_doi 10.1200/JCO.2013.53.8009
10.1001/jamaoncol.2015.0373
10.1093/annonc/mdw538
10.1200/JCO.2016.68.2518
10.1158/1078-0432.CCR-14-1505
10.1093/annonc/mdv249
10.1093/annonc/mdx310
10.1001/jamaoncol.2016.4166
10.1001/jamaoncol.2016.0931
10.1093/annonc/mdx053
10.1200/JCO.2015.61.6706
10.1093/jnci/djx232
10.1136/bmj.j4530
10.1038/bjc.2015.56
10.1016/S1470-2045(17)30415-1
ContentType Journal Article
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1093/jnci/djx261
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2105
EndPage 442
ExternalDocumentID 10_1093_jnci_djx261
29244175
Genre Comment
Journal Article
GroupedDBID ---
-E4
-~X
.2P
.I3
.XZ
.ZR
08P
0R~
1TH
29L
2WC
354
4.4
482
48X
5GY
5RE
5VS
5WD
70D
96U
AABZA
AACZT
AAHTB
AAJKP
AAJQQ
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABCQX
ABEUO
ABIXL
ABJNI
ABKDP
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPPZ
ABPTD
ABQLI
ABQNK
ABXVV
ABZBJ
ACBMB
ACGFO
ACGFS
ACGOD
ACKOT
ACNCT
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AEMDU
AENZO
AEPUE
AETBJ
AEWNT
AFAZI
AFFNX
AFFZL
AFIYH
AFOFC
AFRAH
AFXAL
AGINJ
AGKEF
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ATGXG
BAWUL
BAYMD
BCRHZ
BEYMZ
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EMOBN
ENERS
F5P
F8P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
MHKGH
ML0
N9A
NGC
NOMLY
NOYVH
NPM
NU-
OAUYM
OAWHX
OBH
OCB
OCZFY
ODMLO
ODZKP
OGEVE
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q.-
Q1.
Q5Y
R44
RD5
RHF
RNS
ROL
ROX
ROZ
RUSNO
RW1
RXO
TCURE
TEORI
TJX
TMA
TR2
TWZ
UDS
UPT
VVN
W8F
WH7
WOQ
X7H
YAYTL
YKOAZ
YQT
YXANX
ZKX
ZRR
ZY1
~91
~H1
AASNB
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c326t-f68bfdf85029648418542e67ec91e530a38e306cefd3fd9c6475c4ebfde175ac3
ISSN 0027-8874
IngestDate Fri Oct 25 08:44:49 EDT 2024
Thu Sep 12 17:01:07 EDT 2024
Wed Oct 16 00:48:20 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c326t-f68bfdf85029648418542e67ec91e530a38e306cefd3fd9c6475c4ebfde175ac3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
OpenAccessLink https://academic.oup.com/jnci/article-pdf/110/5/441/24797320/djx261.pdf
PMID 29244175
PQID 1977779772
PQPubID 23479
PageCount 2
ParticipantIDs proquest_miscellaneous_1977779772
crossref_primary_10_1093_jnci_djx261
pubmed_primary_29244175
PublicationCentury 2000
PublicationDate 2018-05-01
20180501
PublicationDateYYYYMMDD 2018-05-01
PublicationDate_xml – month: 05
  year: 2018
  text: 2018-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JNCI : Journal of the National Cancer Institute
PublicationTitleAlternate J Natl Cancer Inst
PublicationYear 2018
References 29244173 - J Natl Cancer Inst. 2018 May 1;110(5):486-492
Vivot ( key 20180510195533_djx261-B17) 2017; 28
Schnipper ( key 20180510195533_djx261-B10) 2015; 33
Savage ( key 20180510195533_djx261-B8) 2015; 112
Del Paggio ( key 20180510195533_djx261-B15) 2017; 18
Davis ( key 20180510195533_djx261-B16) 2017; 359
Cherny ( key 20180510195533_djx261-B11) 2017; 28
Salas-Vega ( key 20180510195533_djx261-B4) 2017; 3
Cherny ( key 20180510195533_djx261-B9) 2015; 26
Del Paggio ( key 20180510195533_djx261-B14) 2017; 28
Tibau ( key 20180510195533_djx261-B13) 2018; 110
Ellis ( key 20180510195533_djx261-B5) 2014; 32
Mailankody ( key 20180510195533_djx261-B3) 2015; 1
Sobrero ( key 20180510195533_djx261-B6) 2015; 21
Kumar ( key 20180510195533_djx261-B7) 2016; 2
key 20180510195533_djx261-B2
Schnipper ( key 20180510195533_djx261-B12) 2016; 34
key 20180510195533_djx261-B1
References_xml – volume: 32
  start-page: 1277
  year: 2014
  ident: key 20180510195533_djx261-B5
  article-title: Raising the bar for clinical trials by defining clinically meaningful outcomes
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.2013.53.8009
  contributor:
    fullname: Ellis
– volume: 1
  start-page: 539
  issue: 4
  year: 2015
  ident: key 20180510195533_djx261-B3
  article-title: Five years of cancer drug approvals: Innovation, efficacy, and costs
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2015.0373
  contributor:
    fullname: Mailankody
– volume: 28
  start-page: 157
  issue: 1
  year: 2017
  ident: key 20180510195533_djx261-B14
  article-title: Do contemporary randomized controlled trials meet ESMO thresholds for meaningful clinical benefit?
  publication-title: Ann Oncol.
  doi: 10.1093/annonc/mdw538
  contributor:
    fullname: Del Paggio
– volume: 34
  start-page: 2925
  year: 2016
  ident: key 20180510195533_djx261-B12
  article-title: Updating ASCO’s value framework: Revisions and reflections in response to comments received
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.2016.68.2518
  contributor:
    fullname: Schnipper
– volume: 21
  start-page: 1036
  year: 2015
  ident: key 20180510195533_djx261-B6
  article-title: Raising the bar for antineoplastic agents: How to choose threshold values for superiority trials in advanced solid tumors
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-14-1505
  contributor:
    fullname: Sobrero
– volume: 26
  start-page: 1547
  year: 2015
  ident: key 20180510195533_djx261-B9
  article-title: A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
  publication-title: Ann Oncol.
  doi: 10.1093/annonc/mdv249
  contributor:
    fullname: Cherny
– volume: 28
  start-page: 2340
  issue: 10
  year: 2017
  ident: key 20180510195533_djx261-B11
  article-title: ESMO Magnitude of Benefit Scale, version 1.1
  publication-title: Ann Oncol.
  doi: 10.1093/annonc/mdx310
  contributor:
    fullname: Cherny
– ident: key 20180510195533_djx261-B1
– ident: key 20180510195533_djx261-B2
– volume: 3
  start-page: 382
  issue: 3
  year: 2017
  ident: key 20180510195533_djx261-B4
  article-title: Assessment of overall survival, quality of life, and safety benefits associated with new cancer medicines
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2016.4166
  contributor:
    fullname: Salas-Vega
– volume: 2
  start-page: 1238
  issue: 9
  year: 2016
  ident: key 20180510195533_djx261-B7
  article-title: An appraisal of clinically meaningful outcomes guidelines for oncology clinical trials
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2016.0931
  contributor:
    fullname: Kumar
– volume: 28
  start-page: 1111
  issue: 5
  year: 2017
  ident: key 20180510195533_djx261-B17
  article-title: Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015
  publication-title: Ann Oncol.
  doi: 10.1093/annonc/mdx053
  contributor:
    fullname: Vivot
– volume: 33
  start-page: 2563
  year: 2015
  ident: key 20180510195533_djx261-B10
  article-title: American Society of Clinical Oncology Statement: A conceptual framework to assess the value of cancer treatment options
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.2015.61.6706
  contributor:
    fullname: Schnipper
– volume: 110
  start-page: 486
  issue: 5
  year: 2018
  ident: key 20180510195533_djx261-B13
  article-title: Magnitude of clinical benefit of cancer drugs approved by the US Food and Drug Administration
  publication-title: J Natl Cancer Inst.
  doi: 10.1093/jnci/djx232
  contributor:
    fullname: Tibau
– volume: 359
  start-page: j4530
  year: 2017
  ident: key 20180510195533_djx261-B16
  article-title: Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicine Agency: Retrospective cohort study of drug approvals 2009-2013
  publication-title: BMJ.
  doi: 10.1136/bmj.j4530
  contributor:
    fullname: Davis
– volume: 112
  start-page: 1037
  year: 2015
  ident: key 20180510195533_djx261-B8
  article-title: Development and economic trend in cancer therapeutic drugs: A 5 year update 2010-2014
  publication-title: Br J Cancer.
  doi: 10.1038/bjc.2015.56
  contributor:
    fullname: Savage
– volume: 18
  start-page: 887
  issue: 7
  year: 2017
  ident: key 20180510195533_djx261-B15
  article-title: Delivery of meaningful cancer care: A retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(17)30415-1
  contributor:
    fullname: Del Paggio
SSID ssj0000924
Score 2.3466797
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 441
Title Hans Christian Andersen and the Value of New Cancer Treatments
URI https://www.ncbi.nlm.nih.gov/pubmed/29244175
https://search.proquest.com/docview/1977779772
Volume 110
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZbB2Mvo7t3l6JB34JbX2RJeSmUkJJuafbijLwZWz6iKcUJbcLGfv2OLr6ErdDtRRjbOpjzyUfnLkKOSsYKJiEJpByigRKLNMB1g2tZQcWGCVMhGD_k5YxP5uzLIl00x7L76pJNeax-_bWu5H9QxXuIq6mS_QdkW6J4A68RXxwRYRwfhPEE9xnfHsD8p2e2UAXqNivye3GzdT4B-DEYGXxvB1mTWX63o5fORhfWO9BTUG36Y-Mr9LPb3IIugHO1vPEOWF-kP5j2HtbL9dqtiunK-gnHfT9DJLusvmNwspHxMEALMd0Rnj4pddmPT1tRyFjU21WZ66H1h8B2zayua2WYXV3_jHnU7UxNNH72LT-fT6d5Nl5kj8mTGGWKjchffO02XbQjffklkjwxBE8cuV2F4x4rwmoT2T557rlMzxymL8gjqF-Sp5c-0eEVOTXQ0hZa2kBLEVqKwFALLV1pitBSBw7toH1N5ufjbDQJ_FEXgUL9eRNoLktdaZmGJgwuTUchFgMXoIYRpElYJPg_hVyBrhJdDRVnIlUMcA6g_leo5A3Zq1c1vCOUCwVCJ6nkumIVCKlVjO9HqYCy1GV8QI4afuRr19Ekd5kISW7Ylju2HZDPDa9ylDgmjFTUsNre5RGaDELggKTeOia2hGKEgeEXvX_A7A_kWbfOPpK9ze0WPqGGtykPLba_AVdYVPI
link.rule.ids 315,783,787,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hans+Christian+Andersen+and+the+Value+of+New+Cancer+Treatments&rft.jtitle=JNCI+%3A+Journal+of+the+National+Cancer+Institute&rft.au=Schilsky%2C+Richard+L&rft.au=Schnipper%2C+Lowell+E&rft.date=2018-05-01&rft.eissn=1460-2105&rft.volume=110&rft.issue=5&rft.spage=441&rft.epage=442&rft_id=info:doi/10.1093%2Fjnci%2Fdjx261&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8874&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8874&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8874&client=summon